Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

Researchers at the University of Waterloo have unlocked the potential of graphene in areas as diverse as vehicles, consumer ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

5 Christiansen MP, Klaff LJ, Brazg R, et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technol Ther. 2018;20(3 ...

Researchers from the University of Virginia Center for Diabetes Technology have found that continuous glucose monitor data can predict if someone is at risk of developing eye, kidney and nerve ...